miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307. The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown bel...
Main Authors: | Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-mir-221-suppression-through-nanoparticle-based-mirna-deliv-peer-reviewed-article-IJN |
Similar Items
-
miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
by: Li F, et al.
Published: (2018-04-01) -
Oncogenic role of miRNA-221/222 in breast cancer
by: I Wayan Ardyan Sudharta Putra, et al.
Published: (2018-05-01) -
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
by: Maria Teresa Di Martino, et al.
Published: (2020-06-01) -
Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis <it>in vitro</it>
by: Rong Minhua, et al.
Published: (2013-01-01) -
EGFR Signaling Pathway and Related-miRNAs In Age-related Diseases: The Example of miR-221 and miR-222
by: Ana L Teixeira, et al.
Published: (2012-12-01)